RAIMONDI, MICHELA
RAIMONDI, MICHELA
Dipartimento di Scienze Farmacologiche e Biomolecolari
Anticancer properties of tocotrienols : a review of cellular mechanisms and molecular targets
2019-02-01 M. Montagnani Marelli, M. Marzagalli, F. Fontana, M. Raimondi, R.M. Moretti, P. Limonta
Ca2+ overload- and ROS-associated mitochondrial dysfunction contributes to δ-tocotrienol-mediated paraptosis in melanoma cells
2021-06-01 M. Raimondi, F. Fontana, M. Marzagalli, M. Audano, G. Beretta, P. Procacci, P. Sartori, N. Mitro, P. Limonta
Cancer Stem Cells—Key Players in Tumor Relapse
2021-01-01 M. Marzagalli, F. Fontana, M. Raimondi, P. Limonta
Cellular and molecular biology of cancer stem cells in melanoma : possible therapeutic implications
2019-06-29 M. Marzagalli, M. Raimondi, F. Fontana, M. Montagnani Marelli, R.M. Moretti, P. Limonta
The emerging role of paraptosis in tumor cell biology: Perspectives for cancer prevention and therapy with natural compounds
2020-01-01 F. Fontana, M. Raimondi, M. Marzagalli, A. Di Domizio, P. Limonta
Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells
2019-02-11 F. Fontana, M. Raimondi, M. Marzagalli, M. Sommariva, P. Limonta, N. Gagliano
Epithelial-to-mesenchymal transition markers are differently expressed in 2D and 3D cell cultures of prostate cancer cells
2018-01-01 F. Fontana, M. Raimondi, M. Marzagalli, F. Bianchi, M. Sommariva, P. Limonta, N. Gagliano
Gonadotropin-releasing hormone receptors in prostate cancer : molecular aspects and biological functions
2020-12-01 F. Fontana, M. Marzagalli, M.M. Marelli, M. Raimondi, R.M. Moretti, P. Limonta
Mitochondria as metabolic markers of melanoma stem cells and targets of delta-tocotrienol
2019-01-01 M. Raimondi, F. Fontana, M. Marzagalli, P. Limonta
Mitochondrial functional and structural impairment is involved in the antitumor activity of δ-tocotrienol in prostate cancer cells
2020-11-20 F. Fontana, M. Raimondi, M. Marzagalli, M. Audano, G. Beretta, P. Procacci, P. Sartori, N. Mitro, P. Limonta
Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets
2020-01-01 F. Fontana, M. Raimondi, M. Marzagalli, A. Di Domizio, P. Limonta
Role of Endoplasmic Reticulum Stress in the Anticancer Activity of Natural Compounds
2019-02-02 P. Limonta, R.M. Moretti, M. Marzagalli, F. Fontana, M. Raimondi, M. Montagnani Marelli
THE KEY ROLE OF MITOCHONDRIA IN HUMAN MELANOMA CELLS: A TARGET OF DELTA-TOCOTRIENOL ANTI-CANCER ACTIVITY AND A STEMNESS MARKER
2021-02-23 M. Raimondi
Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery
2020-09-02 F. Fontana, M. Raimondi, M. Marzagalli, M. Sommariva, N. Gagliano, P. Limonta
Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents
2019-01-15 F. Fontana, M. Raimondi, M. Marzagalli, R.M. Moretti, M.M. Marelli, P. Limonta
Unraveling the molecular mechanisms and the potential chemopreventive/therapeutic properties of natural compounds in melanoma
2019-12-01 F. Fontana, M. Raimondi, A. Di Domizio, R.M. Moretti, M. Montagnani Marelli, P. Limonta
δ‐Tocotrienol induces apoptosis, involving endoplasmic reticulum stress and autophagy, and paraptosis in prostate cancer cells
2019-05-01 F. Fontana, R.M. Moretti, M. Raimondi, M. Marzagalli, G. Beretta, P. Procacci, P. Sartori, M. Montagnani Marelli, P. Limonta
δ‐Tocotrienol sensitizes and re‐sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK‐mediated apoptosis
2021-01-01 F. Fontana, M. Marzagalli, M. Raimondi, V. Zuco, N. Zaffaroni, P. Limonta